vs
BICYCLE THERAPEUTICS PLC（BCYC）与STEM, INC.（STEM）财务数据对比。点击上方公司名可切换其他公司
BICYCLE THERAPEUTICS PLC的季度营收约是STEM, INC.的1.0倍（$48.0M vs $47.1M），STEM, INC.净利率更高（-33.9% vs -42.0%，领先8.1%），BICYCLE THERAPEUTICS PLC同比增速更快（1193.3% vs -15.6%），过去两年BICYCLE THERAPEUTICS PLC的营收复合增速更高（56.7% vs 36.1%）
Bicycle Therapeutics是一家临床阶段生物制药企业，专注于开发双环肽类创新疗法以解决未被满足的医疗需求，核心管线覆盖肿瘤、罕见病与免疫疾病领域，在欧美布局运营，与全球头部药企达成战略合作推进候选药物落地。
该公司是一家公开上市的生物制药企业，总部位于加利福尼亚州纽瓦克，专注研发纯化人类神经干细胞，旨在治疗中枢神经系统疾病与瘫痪，其所研发的神经干细胞可分化为中枢神经系统的神经元、星形胶质细胞与少突胶质细胞这三大主要细胞类型。
BCYC vs STEM — 直观对比
营收规模更大
BCYC
是对方的1.0倍
$47.1M
营收增速更快
BCYC
高出1208.8%
-15.6%
净利率更高
STEM
高出8.1%
-42.0%
两年增速更快
BCYC
近两年复合增速
36.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.0M | $47.1M |
| 净利润 | $-20.2M | $-16.0M |
| 毛利率 | — | 48.9% |
| 营业利润率 | -51.5% | -17.7% |
| 净利率 | -42.0% | -33.9% |
| 营收同比 | 1193.3% | -15.6% |
| 净利润同比 | 61.1% | 68.8% |
| 每股收益（稀释后） | $-0.29 | $-4.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCYCSTEM
| Q4 25 | $48.0M | $47.1M | ||
| Q3 25 | $11.7M | $38.2M | ||
| Q2 25 | $2.9M | $38.4M | ||
| Q1 25 | $10.0M | $32.5M | ||
| Q4 24 | $3.7M | $55.8M | ||
| Q3 24 | $2.7M | $29.3M | ||
| Q2 24 | $9.4M | $34.0M | ||
| Q1 24 | $19.5M | $25.5M |
净利润BCYCSTEM
| Q4 25 | $-20.2M | $-16.0M | ||
| Q3 25 | $-59.1M | $-23.8M | ||
| Q2 25 | $-79.0M | $202.5M | ||
| Q1 25 | $-60.8M | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | $-50.8M | $-148.3M | ||
| Q2 24 | $-39.8M | $-582.3M | ||
| Q1 24 | $-26.6M | $-72.3M |
毛利率BCYCSTEM
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
营业利润率BCYCSTEM
| Q4 25 | -51.5% | -17.7% | ||
| Q3 25 | -558.6% | -33.6% | ||
| Q2 25 | -2965.8% | -34.8% | ||
| Q1 25 | -703.7% | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | -2385.9% | -493.2% | ||
| Q2 24 | -498.3% | -1705.5% | ||
| Q1 24 | -162.4% | -267.0% |
净利率BCYCSTEM
| Q4 25 | -42.0% | -33.9% | ||
| Q3 25 | -503.7% | -62.2% | ||
| Q2 25 | -2703.8% | 527.8% | ||
| Q1 25 | -608.9% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | -1898.4% | -506.3% | ||
| Q2 24 | -425.3% | -1712.6% | ||
| Q1 24 | -136.0% | -283.9% |
每股收益（稀释后）BCYCSTEM
| Q4 25 | $-0.29 | $-4.40 | ||
| Q3 25 | $-0.85 | $-2.84 | ||
| Q2 25 | $-1.14 | $-1.79 | ||
| Q1 25 | $-0.88 | $-0.15 | ||
| Q4 24 | — | $-15.29 | ||
| Q3 24 | $-0.74 | $-18.24 | ||
| Q2 24 | $-0.77 | $-71.81 | ||
| Q1 24 | $-0.62 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $628.1M | $48.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $610.0M | $-249.4M |
| 总资产 | $717.6M | $308.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCYCSTEM
| Q4 25 | $628.1M | $48.9M | ||
| Q3 25 | $648.3M | $43.1M | ||
| Q2 25 | $721.5M | $40.8M | ||
| Q1 25 | $793.0M | $58.6M | ||
| Q4 24 | $879.5M | $56.3M | ||
| Q3 24 | $890.9M | $75.4M | ||
| Q2 24 | $961.4M | $89.6M | ||
| Q1 24 | $457.0M | $112.8M |
总债务BCYCSTEM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $30.9M | — | ||
| Q1 24 | $30.8M | — |
股东权益BCYCSTEM
| Q4 25 | $610.0M | $-249.4M | ||
| Q3 25 | $618.5M | $-235.7M | ||
| Q2 25 | $668.9M | $-214.1M | ||
| Q1 25 | $740.3M | $-417.5M | ||
| Q4 24 | $793.1M | $-398.4M | ||
| Q3 24 | $831.0M | $-344.1M | ||
| Q2 24 | $873.8M | $-203.2M | ||
| Q1 24 | $356.0M | $371.6M |
总资产BCYCSTEM
| Q4 25 | $717.6M | $308.9M | ||
| Q3 25 | $764.0M | $362.6M | ||
| Q2 25 | $832.2M | $379.2M | ||
| Q1 25 | $883.9M | $405.1M | ||
| Q4 24 | $956.9M | $437.4M | ||
| Q3 24 | $996.7M | $537.8M | ||
| Q2 24 | $1.1B | $691.5M | ||
| Q1 24 | $547.1M | $1.3B |
负债/权益比BCYCSTEM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.04× | — | ||
| Q1 24 | 0.09× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.3M | $8.2M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | — |
| 自由现金流率自由现金流/营收 | -41.5% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-252.0M | — |
8季度趋势，按日历期对齐
经营现金流BCYCSTEM
| Q4 25 | $-19.3M | $8.2M | ||
| Q3 25 | $-71.2M | $11.4M | ||
| Q2 25 | $-72.8M | $-21.3M | ||
| Q1 25 | $-86.4M | $8.5M | ||
| Q4 24 | $-164.7M | $-14.7M | ||
| Q3 24 | $-39.8M | $-9.4M | ||
| Q2 24 | $-44.6M | $-11.9M | ||
| Q1 24 | $-70.9M | $-621.0K |
自由现金流BCYCSTEM
| Q4 25 | $-19.9M | — | ||
| Q3 25 | $-71.8M | — | ||
| Q2 25 | $-73.3M | — | ||
| Q1 25 | $-87.0M | — | ||
| Q4 24 | $-166.0M | — | ||
| Q3 24 | $-40.3M | — | ||
| Q2 24 | $-45.0M | — | ||
| Q1 24 | $-70.9M | — |
自由现金流率BCYCSTEM
| Q4 25 | -41.5% | — | ||
| Q3 25 | -612.3% | — | ||
| Q2 25 | -2509.7% | — | ||
| Q1 25 | -871.7% | — | ||
| Q4 24 | -4475.7% | — | ||
| Q3 24 | -1504.7% | — | ||
| Q2 24 | -481.2% | — | ||
| Q1 24 | -362.9% | — |
资本支出强度BCYCSTEM
| Q4 25 | 1.2% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 17.1% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | 16.3% | — | ||
| Q2 24 | 4.5% | — | ||
| Q1 24 | 0.1% | — |
现金转化率BCYCSTEM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
